Search research articles
Contact Us
Filters
Showing results (171-180 of 283) with videos related to
Page
of 29
Sort By:
British Journal of Pharmacology
|
April 29, 2024
Implications and hidden toxicity of cardiometabolic syndrome and early-stage heart failure in carfilzomib-induced cardiotoxicity
Panagiotis Efentakis, Aimilia Varela, Sofia Lamprou, et al.
International Journal of Clinical Oncology
|
October 31, 2018
The combination of bevacizumab/temsirolimus after first-line anti-VEGF therapy in advanced renal-cell carcinoma: a clinical and biomarker study
Aristotelis Bamias, Vasilios Karavasilis, Nikolaos Gavalas, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 29, 2026
BRIDGE (OP-107): A Phase 2 Pharmacokinetic Study of Melflufen Plus Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma and Impaired Renal Function
Ludek Pour, Sosana Delimpasi, Wojciech Legiec, et al.
International Journal of Molecular Sciences
|
July 29, 2023
Real-World Effectiveness and Safety of Belantamab Mafodotin Monotherapy in Triple-Class Refractory Multiple Myeloma
Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Despina Fotiou, et al.
Oncotargets and Therapy
|
August 1, 2015
Expression of ARs in triple negative breast cancer tumors: a potential prognostic factor?
Aris Giannos, Martin Filipits, Flora Zagouri, et al.
Current Oncology (Toronto, Ont.)
|
March 27, 2026
Molecular Profiling and Treatment Outcomes in Uterine Serous Carcinoma: Prognostic Role of Estrogen Receptor Expression
Anna Svarna, Michalis Liontos, Kallirroi Goula, et al.
Blood Cancer Journal
|
March 16, 2025
Refining precision prognostics in multiple myeloma: loss of miR-221/222 cluster in CD138+ plasma cells results in short-term progression and worse treatment outcome
Konstantinos Soureas, Panagiotis Malandrakis, Maria-Alexandra Papadimitriou, et al.
European Journal of Haematology
|
May 23, 2023
Prognostic impact of translocation t(11;14) and of other cytogenetic abnormalities in patients with AL amyloidosis in the era of contemporary therapies
Despina Fotiou, Foteini Theodorakakou, Maria Gavriatopoulou, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 19, 2018
Elevated vWF Antigen Serum Levels Are Associated With Poor Prognosis, and Decreased Circulating ADAMTS-13 Antigen Levels Are Associated With Increased IgM Levels and Features of WM but not Increased vWF Levels in Patients With Symptomatic WM
Maria Gavriatopoulou, Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, et al.
International Journal of Molecular Sciences
|
October 23, 2021
Elucidating Carfilzomib's Induced Cardiotoxicity in an In Vivo Model of Aging: Prophylactic Potential of Metformin
Panagiotis Efentakis, Garyfalia Psarakou, Aimilia Varela, et al.
Page
of 29
Search research articles
Search
Showing results (171-180 of 283) with videos related to
Sort By:
Page
of 29
British Journal of Pharmacology
|
April 29, 2024
Implications and hidden toxicity of cardiometabolic syndrome and early-stage heart failure in carfilzomib-induced cardiotoxicity
Panagiotis Efentakis, Aimilia Varela, Sofia Lamprou, et al.
International Journal of Clinical Oncology
|
October 31, 2018
The combination of bevacizumab/temsirolimus after first-line anti-VEGF therapy in advanced renal-cell carcinoma: a clinical and biomarker study
Aristotelis Bamias, Vasilios Karavasilis, Nikolaos Gavalas, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 29, 2026
BRIDGE (OP-107): A Phase 2 Pharmacokinetic Study of Melflufen Plus Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma and Impaired Renal Function
Ludek Pour, Sosana Delimpasi, Wojciech Legiec, et al.
International Journal of Molecular Sciences
|
July 29, 2023
Real-World Effectiveness and Safety of Belantamab Mafodotin Monotherapy in Triple-Class Refractory Multiple Myeloma
Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Despina Fotiou, et al.
Oncotargets and Therapy
|
August 1, 2015
Expression of ARs in triple negative breast cancer tumors: a potential prognostic factor?
Aris Giannos, Martin Filipits, Flora Zagouri, et al.
Current Oncology (Toronto, Ont.)
|
March 27, 2026
Molecular Profiling and Treatment Outcomes in Uterine Serous Carcinoma: Prognostic Role of Estrogen Receptor Expression
Anna Svarna, Michalis Liontos, Kallirroi Goula, et al.
Blood Cancer Journal
|
March 16, 2025
Refining precision prognostics in multiple myeloma: loss of miR-221/222 cluster in CD138+ plasma cells results in short-term progression and worse treatment outcome
Konstantinos Soureas, Panagiotis Malandrakis, Maria-Alexandra Papadimitriou, et al.
European Journal of Haematology
|
May 23, 2023
Prognostic impact of translocation t(11;14) and of other cytogenetic abnormalities in patients with AL amyloidosis in the era of contemporary therapies
Despina Fotiou, Foteini Theodorakakou, Maria Gavriatopoulou, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 19, 2018
Elevated vWF Antigen Serum Levels Are Associated With Poor Prognosis, and Decreased Circulating ADAMTS-13 Antigen Levels Are Associated With Increased IgM Levels and Features of WM but not Increased vWF Levels in Patients With Symptomatic WM
Maria Gavriatopoulou, Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, et al.
International Journal of Molecular Sciences
|
October 23, 2021
Elucidating Carfilzomib's Induced Cardiotoxicity in an In Vivo Model of Aging: Prophylactic Potential of Metformin
Panagiotis Efentakis, Garyfalia Psarakou, Aimilia Varela, et al.
Page
of 29